The GLoBE Trial.

Does female sex hormone supplementation (FSHS), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)?

This study is the first randomised controlled trial to compare the effectiveness of female sex hormone supplementation therapy alone, and with the combination of exercise therapy, to treat pain and dysfunction associated with greater trochanteric pain syndrome. Post-menopausal women will be recruited and randomised to receive one of two exercise programs (sham or targeted intervention exercise) and transdermal creams (FSHS cream containing oestradiol 50mcg and norethisterone acetate 140mcg or placebo cream).

Staff involved: Charlotte Ganderton, Adam Semciw, Jill Cook, Tania Pizzari

Publication: Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial